Do Outlook Therapeutics, Inc. (OTLK) beta value of 0.26 signposts another twist?

Outlook Therapeutics, Inc. (OTLK) is priced at $0.59 after the most recent trading session. At the very opening of the session, the stock price was $0.55 and reached a high price of $0.67, prior to closing the session it reached the value of $0.54. The stock touched a low price of $0.55.

Outlook Therapeutics, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.70 on 04/01/19, with the lowest value was $0.50 for the same time period, recorded on 03/23/20.

Outlook Therapeutics, Inc. (OTLK) full year performance was -91.94%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Outlook Therapeutics, Inc. shares are logging -93.22% during the 52-week period from high price, and 18.24% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.50 and $8.70.

The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 500209 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Outlook Therapeutics, Inc. (OTLK) recorded performance in the market was -8.47%, having the revenues showcasing -53.04% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 27.10M, as it employees total of 14 workers.

Market experts do have their say about Outlook Therapeutics, Inc. (OTLK)

During the last month, 2 analysts gave the Outlook Therapeutics, Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.9456, with a change in the price was noted -0.6167. In a similar fashion, Outlook Therapeutics, Inc. posted a movement of -50.84% for the period of last 100 days, recording 799,403 in trading volumes.

Technical breakdown of Outlook Therapeutics, Inc. (OTLK)

Raw Stochastic average of Outlook Therapeutics, Inc. in the period of last 50 days is set at 15.67%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 29.40%. In the last 20 days, the company’s Stochastic %K was 17.63% and its Stochastic %D was recorded 13.48%.

Bearing in mind the latest performance of Outlook Therapeutics, Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -8.47%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -67.86%, alongside a downfall of -91.94% for the period of the last 12 months. The shares increased approximately by 7.33% in the 7-day charts and went up by -1.28% in the period of the last 30 days. Common stock shares were lifted by -53.04% during last recorded quarter.